drugset / Trial / NCT02544828

Intravenous Iron Sucrose in Arthroplasty

NCT02544828

Phase 4 Unknown 76 enrolled Konkuk University Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of the present study is to determine the impact of intraoperative IV-iron supplementation on postoperative oxygenation profile by comparing the postoperative PaO2/FiO2 ratio with or without IV-iron supplementation in old patients undergoing elective uni-limb arthroplasty surgery.

Timeline

Start
2015-11
Primary completion
2016-07
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 200 mg Intravenous

Indications